SEC Form 4 · accession 0001437749-18-005702
BIO KEY INTERNATIONAL INC · BKYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Michel
Director
Period of report
Mar 23, 2018
Accepted (ET)
Mar 28, 2018 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001019034
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 23, 2018 | A | 2,041 | $0.00 | A | 3,853 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $1.96 | Mar 23, 2018 | A | 1,500 | A | — | Mar 22, 2025 | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1Represents shares issued to the Reporting Person on March 23, 2018 under the Issuer's 2015 Equity Incentive Plan in payment of board and board committee meeting attendance fees.
- F2Represents shares issuable upon exercise of options granted to the Reporting Person on March 23, 2018 under the Issuer's 2015 Equity Incentive Plan. The options are exercisable at $1.96 per share, the last sale price of the Issuer's common stock as reported on the Nasdaq Capital Market on the date of grant, have a term of seven years, and vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date.